Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The investigators believed the analgesic efficacy of adductor canal block on patients receiving total knee arthroplasty. However, the analgesic effects of different delivery regimens and duration of effects are variable. The investigators hypothesize that using continuous infusion and shorter interval bolus of local anesthetics to perform adductor canal block will reduce pain scale and opioid consumption in patients receiving total knee arthroplasty compared with longer interval bolus of local anesthetics.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:

• Adults receiving unilateral total knee arthroplasty under spinal anesthesia

• American society of anesthesiologists 1-3

Locations
Other Locations
Taiwan
National Cheng Kung University Hospital
RECRUITING
Tainan City
Contact Information
Primary
Wei-Teng Weng, MD
n100390@mail.hosp.ncku.edu.tw
+886-6-2353535
Backup
Chung-Ren Lin, MD.PhD.
n104065@mail.hosp.ncku.edu.tw
+886-6-2353535
Time Frame
Start Date: 2022-11-01
Estimated Completion Date: 2024-09-30
Participants
Target number of participants: 66
Treatments
Experimental: Continuous infusion
adductor canal block with continuous infusion of 0.25% bupivacaine 3.5 ml per hour for 2 days postoperatively
Active_comparator: 12hrs intermittent bolus
adductor canal block with intermittent bolus of 0.25% bupivacaine 21 ml every 12 hours for 2 days postoperatively
Experimental: 6hrs intermittent bolus
adductor canal block with intermittent bolus of 0.25% bupivacaine 21 ml every 6 hours for 2 days postoperatively
Related Therapeutic Areas
Sponsors
Leads: National Cheng-Kung University Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials